Abstract
Under the coronavirus disease 2019 (COVID-19) pandemic, special attention should be paid to minimize the morbidity risk of all infections controlled by specific prophylaxis. During preparation for the epidemic season, the organization and conduct of vaccination against influenza and pneumococcal infection is a particularly crucial task of public health. Priority immunization should be provided to patients from epidemiological and social risk groups. This article presents an overview of the data on pneumococcal infection vaccination efficiency in various population groups as well as on its reasonability for preventing superimposed infection development in COVID-19 infection. In addition to children and decreed groups of the adult population, vaccination against pneumococcal infection is indicated for patients with chronic diseases. This enables us to reduce the risk of complications in case of a new coronavirus infection. Particular attention should be paid to immunizing medical personnel, who are at high risk of infection, play a significant role in controlling the pandemic, and need protection. With the continuous spread of COVID-19, vaccination is necessary in compliance with additional measures to ensure safety (patient routing, disinfection intensification in vaccination rooms, etc.).